Scientific Insights on NMN-C®
Clinical trials on NMN
Scientific research is increasingly focusing on the molecule NMN (nicotinamide mononucleotide) due to its potential in cellular aging and metabolic health. Numerous clinical studies are currently underway or have already been published to evaluate its effectiveness and safety. Here are some official clinical studies.
1. Pre clinical studies (animals & cells)
Prevention of Age-related energy decline (Alessia Grozio for SENEQUE)
Prevention of Heart failure
Improvement of brain function
Anti inflammatory effet comparable to NSAIDs (Aspirin, ibuprofen)
Tolerance and impact on NAD+ levels (Seneque) #2
Impact of NMN on NAD+ metabolism and cellular aging
Efficacy and safety of NMN as an Anti-aging supplement in adults aged 40-65
Increase of NMN on NAD+ metabolism and cellular aging
Effects of NMN on sleep, fatigue, and Physical Performance
Increased endurance and frailty prevention in older adults
Effects of NMN on muscle recovery and physical capacity
NMN improves runners's endurance
Words from Experts
Eric Verdin – President at the Buck Institute
"What really differentiates the NMN from Seneque is the fact that it is fully synthetic, whereas other NMN products on the market actually use enzymatic products, from bacteria, for the last step of the synthesis. So this fully synthetic product is likely to be purer and more efficient at raising NAD+ levels."
➡️ Watch Interview
Alessia Grozio - R&D Seneque Lab
“Seneque has a broad pipeline program of human clinical trial that will be undertaken.”
“We have conducted a toxicology study on NMN-C® that demonstrated high dose, short term and repeated oral administration is safe and did not promote any toxic effects.”
➡️ Watch Interview
Frank Lipman – Leader in Functional Medicine
“I’ve seen the research, I’ve used it myself, I believe in this particular product — that is why I am using NMN-C®.”
➡️ Watch Interview
- Choosing a selection results in a full page refresh.